EmailFacebookXLinkedIn

Fulfilling the potential of HER2-targeting in colorectal cancer: An update on detection and management

Fulfilling the potential of HER2-targeting in colorectal cancer: An update on detection and management

December 31, 2023

touchONCOLOGY has a new learning activity, which we thought might be of interest to you: Fulfilling the potential of HER2-targeting in colorectal cancer: An update on detection and management

Learning Objectives

After watching this activity, participants should be better able to:

  • Discuss the importance of and approaches for detecting HER2 amplifications in patients with CRC
  • Summarize clinical efficacy data for guideline-recommended HER2-targeted treatments for patients with mCRC
  • Appraise investigational evidence and future perspectives for emerging HER2-targeting approaches in HER2-amplified CRC
Overview

In this activity, three experts provide their insights on detection methods for HER2 amplification, as well as the clinical efficacy data for guideline-recommended HER2-targeted therapies and emerging HER2-targeted therapies for patients with mCRC.

This activity is jointly provided by USF Health and touchIME. read more

Stay in touch and share our news!

FacebookXLinkedInWhatsAppEmail

SIOG Head Office

  • International Society of Geriatric Oncology
    P/A Comptabilis
    9 route des Jeunes
    1227 Les Acacias - Switzerland

  • +41 22 734 73 43
  • enquiry@siog.org

ECOSOC Special

In Special Consultative Status with the United Nations Economic and Social Council (ECOSOC).

Quick links

 

Subscribe to our newsletter

By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Powered by K.I.T. Group – Crafted for Excellence

Go to Top